Medicare expands cancer care planning to close coordination gap

What it does

This bill adds Medicare coverage for cancer care planning and coordination services—written treatment plans developed by physicians, physician assistants, or nurse practitioners that incorporate shared decision-making, symptom management, and survivorship planning. Medicare will pay for these plans at the same rate as transitional care management services, starting the year after enactment, with plans furnished at diagnosis, upon treatment changes, at end of active treatment, or upon recurrence.

Why we flagged it

The bill's operative mechanism is straightforward: it adds a new covered service (cancer care planning) to Medicare's benefit package and sets a payment rate. This is routine healthcare coverage legislation, not a tax provision, deregulation, or carve-out.

What the text implies

• Payment rate pegged to transitional care management (CPT 99496) may create downstream pressure on oncology practices to bundle or substitute services, potentially affecting how other cancer-related services are billed or delivered.
• Bill does not specify whether plans must be furnished in-person or can be delegated to non-physician staff, creating potential implementation ambiguity around who actually develops the plan and whether supervision requirements apply.
• Frequency triggers (diagnosis, condition change, end of active treatment, recurrence) are defined by the Secretary, leaving room for regulatory interpretation that could expand or contract actual utilization and cost.
• No explicit carve-out for telehealth or remote delivery, though 'electronically' furnished plans are mentioned; implementation may vary by Medicare Administrative Contractor.
• Bill does not address whether cancer care planning triggers additional coordination payments or whether it is intended as a standalone service, potentially affecting total oncology reimbursement architecture.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Medicare beneficiaries with cancer gain access to structured, coordinated care planning that addresses a documented gap in current practice—particularly for low-income and minority populations historically underserved in cancer care. The bill removes a payment barrier that oncologists report prevents them from offering these plans, directly improving care coordination and shared decision-making without restricting existing benefits or imposing new costs on patients.

Who stands to gain

• oncology practices and physician groups
• physician assistants and nurse practitioners in oncology
• cancer care coordination vendors and EHR vendors
• integrated delivery systems with oncology programs

Named in the bill

Medicare, Social Security Act, Institute of Medicine / National Academy of Medicine, Commission on Cancer, Oncology Care Model, CPT code 99496, Centers for Medicare & Medicaid Services (CMS), BMY (Bristol Myers Squibb), GH (Guardant Health), PFE (Pfizer), DVA (DaVita), JNJ (Johnson & Johnson)

Where it stands

• Aug 13, 2026 — Introduced · Congress.gov: “Introduced in House”
• Aug 13, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.